Results 51 to 60 of about 45,242 (261)

Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis

open access: yesPharmaceuticals, 2022
Human African trypanosomiasis (HAT or ‘sleeping sickness’) is a neglected tropical disease. If untreated, it is always fatal and leads to death. A few treatments are available for HAT, but most of them require a skilled professional, which increases the ...
Mohd Imran   +9 more
doaj   +1 more source

Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: a prospective, open-label, single-arm, phase 2-3, non-randomised study.

open access: yesLancet Global Health
BACKGROUND Rhodesiense human African trypanosomiasis is a neglected disease with epidemic potential that can rapidly become lethal if left untreated. The aim of this study was to show that fexinidazole could offer an alternative to existing treatments ...
E. Matovu   +13 more
semanticscholar   +1 more source

Salivarian Trypanosomes Have Adopted Intricate Host-Pathogen Interaction Mechanisms That Ensure Survival in Plain Sight of the Adaptive Immune System

open access: yesPathogens, 2021
Salivarian trypanosomes are extracellular parasites affecting humans, livestock and game animals. Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense are human infective sub-species of T.
Stefan Magez   +3 more
doaj   +1 more source

New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidine.

open access: yesLancet. Infectious Diseases (Print)
Human African trypanosomiasis is a neglected tropical disease that is usually fatal without treatment. WHO has revised its rhodesiense human African trypanosomiasis treatment guidelines on the basis of an independent systematic literature review and ...
Andreas K. Lindner   +19 more
semanticscholar   +1 more source

Shifting livelihood strategies in northern Nigeria - extensified production and livelihood diversification amongst Fulani pastoralists

open access: yesPastoralism, 2017
This paper presents an in-depth investigation of the livelihood strategies of Fulani pastoralists in north central Nigeria. Results show a diversified crop-livestock system aimed at spreading risk and reducing cattle offtake, adapted to natural resource ...
Ayodele O. Majekodunmi   +4 more
doaj   +1 more source

Experiences with Diagnosis and Treatment of Chagas Disease at a United States Teaching Hospital—Clinical Features of Patients with Positive Screening Serologic Testing

open access: yesTropical Medicine and Infectious Disease, 2021
Chagas disease (CD) is the third most common parasitic infection globally and can cause cardiac and gastrointestinal complications. Around 300,000 carriers of CD live in the U.S., with about 3000 of those in Colorado.
Peter Hyson   +12 more
doaj   +1 more source

Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis

open access: yesFrontiers in Immunology, 2019
Trypanosomiasis has been recognized as a scourge in sub-Saharan Africa for centuries. The disease, caused by protozoan parasites of the Trypanosoma genus, is a major cause of mortality and morbidity in animals and man. Human African trypanosomiasis (HAT),
P. Kennedy, J. Rodgers
semanticscholar   +1 more source

Repurposing the orphan drug nitisinone to control the transmission of African trypanosomiasis

open access: yesbioRxiv, 2020
Tsetse transmit African trypanosomiasis, which is a disease fatal to both humans and animals. A vaccine to protect against this disease does not exist so transmission control relies on eliminating tsetse populations.
M. Sterkel   +17 more
semanticscholar   +1 more source

Chemotherapy of second stage human African trypanosomiasis : comparison between the parenteral diamidine DB829 and its oral prodrug DB868 in vervet monkeys [PDF]

open access: yes, 2015
Human African trypanosomiasis (HAT, sleeping sickness) ranks among the most neglected tropical diseases based on limited availability of drugs that are safe and efficacious, particularly against the second stage (central nervous system [CNS]) of ...
Wang, Michael Z.   +69 more
core   +2 more sources

Home - About - Disclaimer - Privacy